BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16800242)

  • 1. Influenza virus inhibitors available for the chemotherapy and/or chemoprophylaxis of influenza virus infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 2006; 68(2):121-37. PubMed ID: 16800242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis and treatment of influenza virus infection.
    Kandel R; Hartshorn KL
    BioDrugs; 2001; 15(5):303-23. PubMed ID: 11437694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antivirals for influenza in healthy adults: systematic review.
    Jefferson T; Demicheli V; Rivetti D; Jones M; Di Pietrantonj C; Rivetti A
    Lancet; 2006 Jan; 367(9507):303-13. PubMed ID: 16443037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiviral treatment of influenza in humans].
    NĂ¼esch R
    Ther Umsch; 2007 Nov; 64(11):635-41. PubMed ID: 18581908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antivirals for influenza].
    Leophonte P
    Bull Acad Natl Med; 2005 Feb; 189(2):341-55; discussion 355-7. PubMed ID: 16114863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiviral etiotropic chemicals: efficacy against influenza A viruses A subtype H5N1].
    Leneva IA; Shuster AM
    Vopr Virusol; 2006; 51(5):4-7. PubMed ID: 17087058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylaxis and treatment of respiratory infections caused by influenza virus types A and B].
    Reina J
    Rev Esp Quimioter; 1999 Mar; 12(1):23-9. PubMed ID: 10209061
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing influenza: amantadine, rimantadine and beyond.
    Fleming DM
    Int J Clin Pract; 2001 Apr; 55(3):189-95. PubMed ID: 11351773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
    Sauerbrei A; Haertl A; Brandstaedt A; Schmidtke M; Wutzler P
    Med Microbiol Immunol; 2006 Jun; 195(2):65-71. PubMed ID: 16059699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus neuraminidase inhibitors.
    Gubareva LV; Kaiser L; Hayden FG
    Lancet; 2000 Mar; 355(9206):827-35. PubMed ID: 10711940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated treatment for influenza A and B.
    Montalto NJ; Gum KD; Ashley JV
    Am Fam Physician; 2000 Dec; 62(11):2467-76. PubMed ID: 11130232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose oral combination chemoprophylaxis with oseltamivir and amantadine for influenza A virus infections in mice.
    Masihi KN; Schweiger B; Finsterbusch T; Hengel H
    J Chemother; 2007 Jun; 19(3):295-303. PubMed ID: 17594925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase).
    Ryan DM; Ticehurst J; Dempsey MH; Penn CR
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2270-5. PubMed ID: 7840556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
    Sidwell RW; Smee DF; Huffman JH; Barnard DL; Bailey KW; Morrey JD; Babu YS
    Antimicrob Agents Chemother; 2001 Mar; 45(3):749-57. PubMed ID: 11181355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the use of neuraminidase inhibitors for prophylaxis of influenza.
    Kirkbride HA; Watson J
    Commun Dis Public Health; 2003 Jun; 6(2):123-7. PubMed ID: 12889291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
    McKimm-Breschkin JL; Fry AM
    Antiviral Res; 2016 May; 129():21-38. PubMed ID: 26872862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antivirals for pandemic influenza.
    Hayden FG
    J Infect Dis; 1997 Aug; 176 Suppl 1():S56-61. PubMed ID: 9240696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress of anti-influenza virus agents].
    Zhang Q; Zhao QJ; Xiong RS; Li JF; Shen JS
    Yao Xue Xue Bao; 2010 Mar; 45(3):289-99. PubMed ID: 21351503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.